Phenotype / cell stem origin M2-ANLL, acute monocytic leukemia, MDS, T-ALL.
Phenotype / cell stem origin

M2-ANLL, acute monocytic leukemia, MDS, T-ALL.
Etiology
Latency from twenty months to six years after chemotherapy.
Pathology
inv (11) 
Genes involved and Proteins
MLL
Location: 11q23 DNA / RNA 21 exons, spanning over 100 kb; 13-15 kb mRNA. Protein 3969 amino acids; 431 kDa; contains two DNA binding motifs: a AT hook homologous to high mobility group proteins HMGI-(Y) and HMGI(C) that binds to the minor groove of DNA, and zinc fingers, a DNA methyl transferase motif, a bromodomain, and segments of homology with trithorax, in particular in the C-terminal SET domain.
Results of the chromosomal anomaly
Hybrid gene
Description
MLL-MAML2
Transcript MLL-MAML2; exon 1-7 of MLL fused to exons 2-5 of MAML2.
Fusion protein
Description
Hybrid transcript MLL/MAML2 contains the following domains: -from MLL: AT-hook, DNA-Methyltransferase; -from MAML2: Q rich domain, acidic domain.
Expression localisation
In the nucleus.
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